Similar articles

• [Immune reactivity and immunomodulator-induced changes in bronchopulmonary infections].

  Algeorge G, Stoian M, Petre A, Bănică D, Molan M, Bercea O, Morgenstern H. Algeorge G, et al. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1987 Jan-Mar;36(1):57-66. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1987. PMID: 3033801 Romanian. No abstract available.
• Broncho-vaxom, representative drug of a new therapeutical concept in lung pathology (present and future outlooks).

  Mihălţan F, Popescu O. Mihălţan F, et al. Pneumoftiziologia. 1991 Jan-Mar;40(1):25-33. Pneumoftiziologia. 1991. PMID: 1823193 Review. No abstract available.
• [Comparative effectiveness of immunomodulators in the therapy of bronchopulmonary diseases].

  Zemskov AM, Provotorov VM, Nikitin AV, Zemskov VM. Zemskov AM, et al. Antibiotiki. 1984 Sep;29(9):673-6. Antibiotiki. 1984. PMID: 6508258 Russian.
• [Tissue immunopathology methods for the diagnosis of bronchopulmonary diseases].

  Janin-Mercier A, Mignot P, Delage J, Molina C. Janin-Mercier A, et al. Rev Pneumol Clin. 1985;41(4):238-44. Rev Pneumol Clin. 1985. PMID: 3909343 French.
• [The non-gas-exchange functions of the lungs and the role of their disorders in the development of bronchopulmonary complications].

  Skobel'skiĭ VB. Skobel'skiĭ VB. Anesteziol Reanimatol. 1996 May-Jun;(3):63-8. Anesteziol Reanimatol. 1996. PMID: 8967626 Review. Russian. No abstract available.